Cardiac channelopathies in pediatric patients-7-years single center experience

被引:3
作者
Illikova, V. [1 ,2 ,3 ]
Hlivak, P.
Hatala, R.
机构
[1] Comenius Univ, Sch Med, Dept Arrhythmias & Pacing, Childrens Cardiac Ctr, Bratislava, Slovakia
[2] Comenius Univ, Sch Med, Dept ICU, Childrens Cardiac Ctr, Bratislava, Slovakia
[3] Slovak Med Univ, Sch Med, Natl Cardiovasc Inst, Bratislava, Slovakia
关键词
Channelopathy; Genetic testing; Children; LONG-QT SYNDROME; MANAGEMENT; GENETICS;
D O I
10.1016/j.jelectrocard.2014.11.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Channelopathies are associated with mutations of genes encoding proteins creating or interacting with the specialized ion channels in myocardial cell membranes, thus forming arrhythmogenic substrate predisposing the patient to sudden cardiac death. The study focuses the clinical and ECG presentation and management of children with channelopathies in Slovakia. Subject and methods: Twenty-two children with suspected channelopathy were admitted to Children's Cardiac Center Bratislava in the years 2007-2014. Genetic testing was made in 19 patients. Results: Fourteen patients were symptomatic. Long QT syndrome was genetically proven in eight and catecholaminergic polymorphic ventricular tachycardia in five patients. Twenty children are treated with beta-blockers, five in combination with mexiletine or flecainide. Nine patients received implantable cardiac defibrillator and one underwent left cardiac sympathetic denervation. Conclusion: Both clinical presentation and genetic testing must be considered in the diagnostic and therapeutic process of channelopathies. Early diagnosis allows for adequate treatment and lifestyle modification. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:150 / 156
页数:7
相关论文
共 10 条
  • [1] HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
    Ackerman, Michael J.
    Priori, Silvia G.
    Willems, Stephan
    Berul, Charles
    Brugada, Ramon
    Calkins, Hugh
    Camm, A. John
    Ellinor, Patrick T.
    Gollob, Michael
    Hamilton, Robert
    Hershberger, Ray E.
    Judge, Daniel P.
    Le Marec, Herve
    McKenna, William J.
    Schulze-Bahr, Eric
    Semsarian, Chris
    Towbin, Jeffrey A.
    Watkins, Hugh
    Wilde, Arthur
    Wolpert, Christian
    Zipes, Douglas P.
    [J]. EUROPACE, 2011, 13 (08): : 1077 - 1109
  • [2] Long QT syndrome
    Goldenberg, Ilan
    Moss, Arthur J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (24) : 2291 - 2300
  • [3] Cardiac channelopathies
    Marbán, E
    [J]. NATURE, 2002, 415 (6868) : 213 - 218
  • [4] Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014
  • [5] Impact of Genetics on the Clinical Management of Channelopathies
    Schwartz, Peter J.
    Ackerman, Michael J.
    George, Alfred L., Jr.
    Wilde, Arthur A. M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (03) : 169 - 180
  • [6] Long-QT Syndrome From Genetics to Management
    Schwartz, Peter J.
    Crotti, Lia
    Insolia, Roberto
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (04) : 868 - 877
  • [7] Schwartz PJ, 2001, CIRCULATION, V103, P89
  • [8] Postmortem long QT syndrome genetic testing for sudden unexplained death in the young
    Tester, David J.
    Ackerman, Michael J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (02) : 240 - 246
  • [9] Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice
    Tester, David J.
    Ackerman, Michael J.
    [J]. CIRCULATION, 2011, 123 (09) : 1021 - 1037
  • [10] Tester DJ, 2008, CONGENITAL LONG QT S, P462